Epigral Targets Rs 5,000 Crore Revenue by FY31 via Chemical Capacity Expansion
Epigral is targeting Rs 5,000 crore in revenue by FY31 through chemical capacity expansion, as reported on 28 September 2026. Projects India already tracks two Epigral projects in Bharuch, Gujarat.